SCHEMBL5692145

SCHEMBL5692145

CCCc1cc(CC[Si](C)(C)C)cc(CCC)c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 2/20 0.42
HMGCR P04035 1/20 0.35
PTGS2 P35354 3/20 0.34
CYP3A4 P08684 1/20 0.34
ALOX5 P09917 4/20 0.33
MAOA P21397 1/20 0.33
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
GABRA1 P14867 3/20 0.33
GABRB2 P47870 3/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
ESR1 P03372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5692024 0.89 HTT (0.43) PTGS2CYP3A4ALOX5MAOANPC1
SCHEMBL9192220 0.89 DHFR (0.42) DHFRHMGCRPTGS2CYP3A4ALOX5
SCHEMBL5692252 0.86 DHFR (0.41) DHFRPTGS2CYP3A4NPC1HPGD
SCHEMBL8385660 0.85 ALOX5 (0.37) DHFRALOX5NPC1RAB9ACNR1
SCHEMBL1023215 0.83 DHFR (0.45) DHFRHMGCRPTGS2CYP3A4ALOX5
SCHEMBL9193282 0.83 DHFR (0.41) DHFRHMGCRPTGS2CYP3A4ALOX5
SCHEMBL7335230 0.82 DHFR (0.42) DHFRHMGCRPTGS2CYP3A4ALOX5
SCHEMBL9306738 0.80 DHFR (0.40) DHFRPTGS2CYP3A4ALOX5NPC1
SCHEMBL10595573 0.79 PTGS2 (0.48) DHFRHMGCRPTGS2CYP3A4ALOX5
SCHEMBL5692097 0.79 ALOX5 (0.39) DHFRALOX5MAOANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1468692-B1 Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma MERRELL PHARMA INC (US) 2006-04-26 EP disclosed
EP-0732928-B1 METHOD OF LOWERING SERUM CHOLESTEROL LEVELS WITH 2,6-DI-ALKYL-4-SILYL-PHENOLS MERRELL PHARMA INC (US) 2004-12-22 EP disclosed
EP-1468693-A2 Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus MERRELL PHARMACEUTICALS INC. (US) 2004-10-20 EP disclosed
EP-1468692-A2 Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma MERRELL PHARMACEUTICALS INC. (US) 2004-10-20 EP disclosed
CN-1216921-A Method for inducing vascular cell adhesion molecule-1 and treating chronic inflammatory diseases using 2, 6-dialkyl-4-silyl-phenols HOECHST MARION ROUSSEL INC (US) 1999-05-19 CN disclosed
US-5795876-A ANTIINFLAMMATORY AGENTS HOECHST MARION ROUSSSEL, INC. (US) 1998-08-18 US disclosed
US-5532400-A 2,6-di-alkyl-4-silyl-phenols as antiatheroscelerotic agents MERRELL PHARMACEUTICALS INC. (US) 1996-07-02 US disclosed
EP-0464852-B1 Novel 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents and as antioxidants MERRELL DOW PHARMA (US) 1996-03-20 EP disclosed
CN-1029615-C Novel 2,6-Di-alkyl-4-silyl-phenols as antiatherosclerotic agents MERRELL DOW PHARMA (US) 1995-08-30 CN disclosed
US-5155250-A 2,6-DI-ALKYL-4-SILYL-PHENOLS AS ANTIATHEROSCEROTIC AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1992-10-13 US disclosed
CN-1057843-A New 2 as antiatherosclerotic, 6-two-alkyl-4-silyl-phenols MERRELL DOW PHARMA (US) 1992-01-15 CN disclosed